Literature DB >> 8466380

Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. A possible consequence of a destructive process in the thyroid.

E Roti1, R Minelli, E Gardini, L Bianconi, L E Braverman.   

Abstract

Amiodarone is an iodine-rich drug used in the treatment of resistant cardiac arrhythmias. Amiodarone-induced thyrotoxicosis (AIT) is well recognized and is generally believed to be due to the excess iodine released from the metabolism of the drug, although amiodarone-associated thyroiditis has occasionally been observed. We report the clinical, laboratory, and therapeutic course of nine patients with AIT. The thyrotoxic phase was often followed by mild hypothyroidism during and after antithyroid drug or corticosteroid therapy. The thyroid was tender to palpation in two patients and a fine-needle aspiration biopsy of the thyroid revealed changes consistent with thyroiditis in three patients who underwent biopsy. These findings strongly suggest that the etiology of AIT, at least in some patients, is due, in part, to drug-induced inflammatory changes in the thyroid, as has been reported to occur in lung, bone marrow, and testes. Thus, the AIT may be due to excess iodine, drug-induced thyroiditis, or a combination of the two. The favorable response of AIT to corticosteroids in occasional patients previously reported also suggests that acute thyroiditis was probably present.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8466380

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  13 in total

1.  Atrial fibrillation due to late amiodarone-induced thyrotoxicosis.

Authors:  Ibrahim Halil Kurt; Talat Yigit; Bulent Mustafa Karademir
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

2.  Diagnostic enigmas in thyroid disease.

Authors:  K A Woeber
Journal:  West J Med       Date:  1996-02

Review 3.  Pulmonary hypertension in thyroid diseases.

Authors:  Pietro Scicchitano; Ilaria Dentamaro; Francesco Tunzi; Gabriella Ricci; Santa Carbonara; Fiorella Devito; Annapaola Zito; Anna Ciampolillo; Marco Matteo Ciccone
Journal:  Endocrine       Date:  2016-03-19       Impact factor: 3.633

4.  Ultrastructural evidence of thyroid damage in amiodarone-induced thyrotoxicosis.

Authors:  E Cappiello; R Boldorini; A Tosoni; S Piraneo; R Bernasconi; U Raggi
Journal:  J Endocrinol Invest       Date:  1995-12       Impact factor: 4.256

5.  High prevalence of thyroid dysfunction in adult patients with beta-thalassemia major submitted to amiodarone treatment.

Authors:  S Mariotti; A Loviselli; S Murenu; F Sau; L Valentino; A Mandas; S Vacquer; E Martino; A Balestrieri; M E Lai
Journal:  J Endocrinol Invest       Date:  1999-01       Impact factor: 4.256

6.  Management of amiodarone-related thyroid problems.

Authors:  Shashithej K Narayana; David R Woods; Christopher J Boos
Journal:  Ther Adv Endocrinol Metab       Date:  2011-06       Impact factor: 3.565

7.  Thyroid color flow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis.

Authors:  F Bogazzi; E Martino; E Dell'Unto; S Brogioni; C Cosci; F Aghini-Lombardi; C Ceccarelli; A Pinchera; L Bartalena; L E Braverman
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

8.  Thyroid ultrasonography in patients with a previous episode of amiodarone induced thyrotoxicosis.

Authors:  E Roti; L Bianconi; F De Chiara; R Minelli; C Tosi; E Gardini; M Salvi; L E Braverman
Journal:  J Endocrinol Invest       Date:  1994-04       Impact factor: 4.256

9.  Potassium perchlorate only temporarily restores euthyroidism in patients with amiodarone-induced hypothyroidism who continue amiodarone therapy.

Authors:  F Bogazzi; L Bartalena; L Tomisti; E Dell'Unto; C Cosci; C Sardella; M L Tanda; A Lai; M Gasperi; F Aghini-Lombardi; E Martino
Journal:  J Endocrinol Invest       Date:  2008-06       Impact factor: 4.256

10.  Subclinical hypothyroidism, overt thyrotoxicosis and subclinical hypothyroidism: the subsequent phases of thyroid function in a patient chronically treated with amiodarone.

Authors:  R Minelli; E Gardini; L Bianconi; M Salvi; E Roti
Journal:  J Endocrinol Invest       Date:  1992-12       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.